Antibiotics are a class of secondary metabolites with anti-pathogen or other activities produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants in the process of life, and can interfere with the developmental functions of other living cells. Chemical substances. Antibiotics commonly used in clinics include extracts from microbial culture fluids and chemically synthesized or semi-synthetic compounds. There are no less than 10,000 known natural antibiotics.
According to a survey by the World Health Organization, about 75% of outpatient cold patients in China use antibiotics, and the rate of antibiotic use in hospitalized patients is as high as 80%. Because the abuse of antibiotics can easily lead to the adverse consequences of rising bacterial resistance, my country has been strengthening the management and control of the use of antibiotics to prevent the abuse of antibiotics. In August 2012, the "Administrative Measures for the Clinical Application of Antibacterial Drugs" began to be implemented, and each province issued a corresponding hierarchical management system. In May 2018, the National Health Commission once again issued a notice on the clinical management of antimicrobial drugs, and the policy intensity remains unchanged. In terms of clinical dosage, anti-infective drugs are still the most used drugs.
In recent years, under the implementation of anti-resistance measures such as graded management of antibiotics, the scale of my country's antibiotic market has grown slowly. With the acceleration of the aging process of my country's population and the expansion of national medical insurance investment, it is expected that the antibiotic industry will maintain a large demand in the next few years. China Business Industry Research Institute predicts that my country's antibiotic market will reach 186.3 billion yuan and 194.5 billion yuan in 2021 and 2022, respectively.
